TNFSF11 and osteoporosis: Apart from normal bone remodeling, RANKL also drives disease-related bone resorption, particularly in osteoporosis, where an imbalance in the RANKL-to-OPG ratio leads to excessive osteoclast activity and bone resorption, resulting in reduced bone strength and an increased risk of fractures [9].